Source:http://linkedlifedata.com/resource/pubmed/id/10475358
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1999-10-4
|
pubmed:abstractText |
Extraprostatic extension of prostatic adenocarcinoma (pathologic Stage T3) increases the risk of recurrence after radical prostatectomy compared with organ-confined prostate cancer. Use of microvessel density in predicting cancer recurrence in Stage pT3 cancer is poorly understood. We evaluated known predictors of recurrence, including Gleason grade, preoperative serum prostate-specific antigen (PSA), DNA ploidy, seminal vesicle involvement, and surgical margin status in comparison with optimized microvessel density (OMVD) and area-weighted microvessel density (AWMVD) in patients with Stage pT3 prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1527-9995
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
54
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
479-85
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10475358-Adenocarcinoma,
pubmed-meshheading:10475358-Adult,
pubmed-meshheading:10475358-Follow-Up Studies,
pubmed-meshheading:10475358-Humans,
pubmed-meshheading:10475358-Male,
pubmed-meshheading:10475358-Microcirculation,
pubmed-meshheading:10475358-Middle Aged,
pubmed-meshheading:10475358-Neoplasm Metastasis,
pubmed-meshheading:10475358-Neoplasm Recurrence, Local,
pubmed-meshheading:10475358-Neoplasm Staging,
pubmed-meshheading:10475358-Ploidies,
pubmed-meshheading:10475358-Predictive Value of Tests,
pubmed-meshheading:10475358-Prostate-Specific Antigen,
pubmed-meshheading:10475358-Prostatectomy,
pubmed-meshheading:10475358-Prostatic Neoplasms
|
pubmed:year |
1999
|
pubmed:articleTitle |
Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
|
pubmed:affiliation |
Department of Urology, Mayo Clinic, Rochester, Minnesota, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|